M. T. Rilla

Clinical baseline factors predict response to natalizumab: their usefulness in patient selection

M. Sormani, A. Uccelli, G. Mancardi, 2014, BMC Neurology.

Effect of SARS-CoV-2 mRNA vaccination in MS patients treated with disease modifying therapies

M. Ulivelli, G. Marfia, M. Sormani, 2021, EBioMedicine.

Breakthrough SARS-CoV-2 infections in MS patients on disease-modifying therapies

M. Ulivelli, M. Sormani, R. Iodice, 2022, medRxiv.